Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 ≤20%

Simple item page
dc.contributor.authorÖzaslan, E
dc.contributor.authorKoca, S
dc.contributor.authorSevinç, A
dc.contributor.authorHacioglu, B
dc.contributor.authorÖzçelik, M
dc.contributor.authorDuran, AO
dc.contributor.authorYildiz, Y
dc.contributor.authorTanriverdi, Ö
dc.contributor.authorMenekse, S
dc.contributor.authorAksoy, A
dc.contributor.authorElmaci, S
dc.contributor.authorUysal, M
dc.contributor.authorÇiltas, A
dc.date.accessioned2024-07-18T12:07:44Z
dc.date.available2024-07-18T12:07:44Z
dc.identifier.issn0028-3835
dc.identifier.other1423-0194
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10600
dc.language.isoEnglish
dc.publisherKARGER
dc.titleComparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 ≤20%
dc.typeMeeting Abstract

Files

Collections

Web of Science Koleksiyonu